Journal Mobile Options
Table of Contents
Vol. 14, No. 3, 1999
Issue release date: May–June 1999

Differential Effect of Advanced Maternal Age on Prenatal Diagnosis of Trisomies 13, 18 and 21

Drugan A. · Yaron Y. · Zamir R. · Ebrahim S.A.D. · Johnson M.P. · Evans M.I.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Nondisjunction associated with advanced maternal age, a well-established factor in the etiology of autosomal trisomy, should equally affect all chromosomes. In this study we evaluate the association of advanced maternal age with the occurrence of potentially viable autosomal trisomies (13, 18 and 21). 275 aneuploid pregnancies were ascertained prenatally and were grouped according to chromosome anomaly diagnosed. Mean maternal age was significantly younger (p = 0.009) in pregnancies affected by trisomy 13 than in pregnancies with trisomy 21. An intermediate mean maternal age was observed in pregnancies affected by trisomy 18. Our study shows a trend of the more severe, but potentially viable, autosomal trisomies to be diagnosed at younger maternal age. This may substantiate the ‘relaxed selection hypothesis’ proposed to explain the association of aneuploid conceptions with advanced maternal age.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Warburton D, Kinney A: Chromosomal differences in susceptability to meiotic aneuploidy. Environ Mol Mutagen 1996;28:237–247.
  2. Wyrobek AJ, Aardema M, Eichenlaub-Ritter U, Ferguson L, Marchetti F: Mechanisms and targets involved in maternal and paternal age effects on numerical aneuploidy. Environ Mol Mutagen 1996;28:254–264.
  3. Eggerman T, Nothen MM, Eiben B, Hofman D, Hinkel K, Fimmers R, Schwanitz G: Trisomy of human chromosome 18: Molcecular studies on parental origin and cell stage of non-disjunction. Hum Genet 1996;97:218–223.

    External Resources

  4. Ramesh KH, Verma RS: Parental origin of the xetra chromosome 18 in Edwards syndrome. Ann Genet 1996;39:110–112.
  5. Hassold T, Merrill M, Adkins K, Freeman S, Sherman S: Recombination and maternal age dependent nondisjunction: Molecular studies of trisomy 16. Am J Hum Genet 57:867–874.
  6. Zaragoza MV, Jacobs PA, James RS, Rogan P, Sherman S, Hassold T: Nondisjunction of human acrocentric chromosomes: Studies of 432 trisomic fetuses. Hum Genet 1994;94:411–417.

    External Resources

  7. Abruzzo MA, Hassold TJ: Etiology of nondisjunction in humans. Environ Mol Mutagen 1995;25:(suppl 26p):38–47.
  8. Delhanty JDA, Handyside AH: The origin of genetic defects in the human and their detection in the preimplantation embryo. Hum Reprod Update 1995;1:201–215.
  9. Drugan A, Johnson MP, Isada NB, Evans MI: Age of gestation (size) at embryonic demise: Tailoring counseling for lethal versus potentially viable aneuploidy. Fetal Diagn Ther 1993;8:178–181.
  10. Hook EB, Cross PK, Regal RR: The frequency of 47, +21, 47, +18 and 47, +13 at the uppermost extremes of maternal ages: Results of 56,094 fetuses studied prenatally and comparisons with data on livebirths. Hum Genet 1984;68:211–220.

    External Resources

  11. Ferguson-Smith MA, Yates JRW: Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative European study on 52,965 amniocenteses. Prenat Diagn 1984;4:5–44.

    External Resources

  12. Risch N, Stein Z, Kline J, Warburton D: The relationship between maternal age and chromosome size in autosomal trisomy. Am J Hum Genet 1986;39:68–78.
  13. Jacobs PA, Hassold TJ, Henry A, Pettay D, Takaesu N: Trisomy 13 ascertained in a survey of spontaneous abortions. J Med Genet 1987;24:721–724.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50